Clinical Trials · NCT07671391
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 60
- Start date
- Aug 2026
- Locations
- See registry
- Primary endpoint
- The percentage change in lean body mass